Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan P Mueller

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Radiology|August 5, 2008
Osteoblastic response as a healing reaction to chemotherapy mimicking progressive disease in patients with small cell lung cancerJoerg Stattaus, Steffen Hahn, Thomas Gauler, et al.
AJR. American Journal of Roentgenology|November 20, 2002
Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materialsGerald Antoch, Lutz S Freudenberg, Joerg Stattaus, et al.
Investigative Radiology|November 25, 2003
Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imagingGerald Antoch, Walter Jentzen, Lutz S Freudenberg, et al.
Cancer Immunology, Immunotherapy : CII|March 31, 2015
Impairment of lymphocyte function following yttrium-90 DOTATOC therapyVahé Barsegian, Christian Hueben, Stefan P Mueller, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2019
DNA lesions correlate with lymphocyte function after selective internal radiotherapyAglaia Domouchtsidou, Vahé Barsegian, Stefan P Mueller, et al.
Cancer Immunology, Immunotherapy : CII|March 4, 2018
Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapyAglaia Domouchtsidou, Vahé Barsegian, Stefan P Mueller, et al.
Cancers|August 26, 2023
In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of SurvivalAglaia Domouchtsidou, Ferdinand Beckmann, Beate Marenbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PETGerald Antoch, Nina Saoudi, Hilmar Kuehl, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Safety and Efficacy of Selective Internal Radionuclide Therapy with <sup>90</sup>Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial ChemoembolizationAlexander Bellendorf, Nicolai Mader, Stefan P Mueller, et al.
Radiology|February 7, 2004
Intraoperative radiation therapy in liver tissue in a pig model: monitoring with dual-modality PET/CTGerald Antoch, Gernot M Kaiser, Andrea B Mueller, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Radiology|August 5, 2008
Osteoblastic response as a healing reaction to chemotherapy mimicking progressive disease in patients with small cell lung cancerJoerg Stattaus, Steffen Hahn, Thomas Gauler, et al.
AJR. American Journal of Roentgenology|November 20, 2002
Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materialsGerald Antoch, Lutz S Freudenberg, Joerg Stattaus, et al.
Investigative Radiology|November 25, 2003
Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imagingGerald Antoch, Walter Jentzen, Lutz S Freudenberg, et al.
Cancer Immunology, Immunotherapy : CII|March 31, 2015
Impairment of lymphocyte function following yttrium-90 DOTATOC therapyVahé Barsegian, Christian Hueben, Stefan P Mueller, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2019
DNA lesions correlate with lymphocyte function after selective internal radiotherapyAglaia Domouchtsidou, Vahé Barsegian, Stefan P Mueller, et al.
Cancer Immunology, Immunotherapy : CII|March 4, 2018
Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapyAglaia Domouchtsidou, Vahé Barsegian, Stefan P Mueller, et al.
Cancers|August 26, 2023
In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of SurvivalAglaia Domouchtsidou, Ferdinand Beckmann, Beate Marenbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PETGerald Antoch, Nina Saoudi, Hilmar Kuehl, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Safety and Efficacy of Selective Internal Radionuclide Therapy with <sup>90</sup>Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial ChemoembolizationAlexander Bellendorf, Nicolai Mader, Stefan P Mueller, et al.
Radiology|February 7, 2004
Intraoperative radiation therapy in liver tissue in a pig model: monitoring with dual-modality PET/CTGerald Antoch, Gernot M Kaiser, Andrea B Mueller, et al.
Pageof 1